Sort
40,608 grants matching “prostate cancer”
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
$677,064Corinne E. Joshu · Johns Hopkins University · R01 · FY2021 · CA
Precision magnetic hyperthermia by integrating magnetic particle imaging
$677,029Robert Ivkov · Johns Hopkins University · R01 · FY2021 · CA
Improving Cancer Outcomes for African-Americans
$677,000Patrick D Maguire · New Hanover Regional Medical Center · U56 · FY2007 · CA
Prostate Cancer Studies
$676,908Michael Cook · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Promoting Equity of Cancer Screening and Follow-up for Lung Cancer.
$676,845Chyke Abadama Doubeni · Ohio State University · R01 · FY2025 · CA
Motion-Resolved, Comprehensive Quantitative Tissue Characterization Using MR Multitasking
$676,760Debiao Li · Cedars-Sinai Medical Center · R01 · FY2019 · EB
Chemoprevention of Prostate Cancer, HDAC Inhibition, and DNA Methylation
$676,744Emily Ho · Oregon State University · P01 · FY2010 · CA
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
$676,729Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
Shanghai Men's Health Study
$676,671Xiao-Ou Shu · Vanderbilt University Medical Center · UM1 · FY2015 · CA
Development of the Next Generation of FABP5 Inhibitors to Treat Prostate Cancer
$676,650Iwao Ojima · State University New York Stony Brook · R01 · FY2021 · CA
Systematic Testing of a TGFβ Targeted Theranostic in Preclinical Cancer
$676,567Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2025 · CA
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial
$676,561Amir Goldkorn · University Of Southern California · R01 · FY2015 · CA
Leadership, Planning, and Evaluation
$676,378Stanton L Gerson · Case Western Reserve University · P30 · FY2019 · CA
Drug Development for Prostate Cancer and other Metastatic Processes
$676,338William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Molecular Risk Stratification for Colonoscopic Surveillance
$676,118Andrew T Chan · Massachusetts General Hospital · U01 · FY2016 · CA
Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer
$676,023Amir Goldkorn · University Of Southern California · R01 · FY2022 · CA
Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer
$676,022Amir Goldkorn · University Of Southern California · R01 · FY2023 · CA
Human Proteome Arrays for Auto-Antibody Identification in Clinical Cancer Studies
$675,834John H Kenten · Meso Scale Diagnostics, Llc · R44 · FY2009 · CA
Quantifying and Characterizing the shared genetic contribution to common cancers
$675,732Sara Lindstroem · Harvard School Of Public Health · U01 · FY2015 · CA
PROSTATE CANCER GRADE MAPPING WITH TRANSRECTAL ELECTRICAL IMPEDANCE TOMOGRAPHY
$675,731Trustees Of Dartmouth College · · FY2015 · Department of the Army
THE CONTRIBUTION OF RARE VARIANTS IN FAMILIAL CLUSTERING OF PROSTATE AND BREAST CANCER IN AFRICAN AMERICANS
$675,729Wayne State University · · FY2017 · Department of the Army
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
$675,718Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2022 · CA
Multimodal dendrimer theranostics targeting aggressive subtypes of prostate cancer
$675,688Martin G Pomper · Ut Southwestern Medical Center · R01 · FY2025 · CA
Radiation-induced translational control of gene expression
$675,650Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$675,590Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA